ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,120 | -72.6% | 14,622 | 0.0% | 0.00% | – |
| Q2 2023 | $7,750 | -98.4% | 14,622 | -93.8% | 0.00% | – |
| Q3 2022 | $481,000 | +108.2% | 235,800 | +29.0% | 0.00% | – |
| Q2 2022 | $231,000 | +755.6% | 182,800 | +2189.9% | 0.00% | – |
| Q1 2021 | $27,000 | -90.4% | 7,983 | -91.3% | 0.00% | – |
| Q4 2020 | $282,000 | +57.5% | 91,542 | +34.1% | 0.00% | – |
| Q3 2020 | $179,000 | -27.2% | 68,263 | -9.5% | 0.00% | – |
| Q2 2020 | $246,000 | +54.7% | 75,467 | +13.0% | 0.00% | – |
| Q1 2020 | $159,000 | -79.2% | 66,800 | -58.7% | 0.00% | – |
| Q4 2019 | $763,000 | +88.4% | 161,869 | +70.7% | 0.00% | – |
| Q3 2019 | $405,000 | -27.3% | 94,849 | -0.7% | 0.00% | – |
| Q2 2019 | $557,000 | -26.0% | 95,518 | -51.2% | 0.00% | – |
| Q1 2019 | $753,000 | +19.3% | 195,783 | -42.0% | 0.00% | – |
| Q4 2018 | $631,000 | +12.9% | 337,413 | +93.4% | 0.00% | – |
| Q3 2018 | $559,000 | +48.3% | 174,507 | +40.1% | 0.00% | – |
| Q2 2018 | $377,000 | -32.2% | 124,533 | -12.1% | 0.00% | – |
| Q1 2018 | $556,000 | -58.9% | 141,600 | -56.7% | 0.00% | -100.0% |
| Q4 2017 | $1,354,000 | -29.6% | 327,200 | +4.5% | 0.00% | 0.0% |
| Q3 2017 | $1,922,000 | -21.1% | 313,200 | -20.0% | 0.00% | 0.0% |
| Q2 2017 | $2,436,000 | -9.8% | 391,600 | -8.1% | 0.00% | 0.0% |
| Q1 2017 | $2,701,000 | +70.2% | 426,000 | +73.9% | 0.00% | 0.0% |
| Q4 2016 | $1,587,000 | +1.5% | 245,000 | -11.7% | 0.00% | 0.0% |
| Q3 2016 | $1,563,000 | +5.4% | 277,600 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $1,483,000 | -23.5% | 270,000 | +3.4% | 0.00% | 0.0% |
| Q1 2016 | $1,938,000 | +1897.9% | 261,195 | +2133.4% | 0.00% | – |
| Q4 2015 | $97,000 | -7.6% | 11,695 | 0.0% | 0.00% | – |
| Q3 2015 | $105,000 | +43.8% | 11,695 | +92.6% | 0.00% | – |
| Q2 2015 | $73,000 | +15.9% | 6,071 | +4.3% | 0.00% | – |
| Q1 2015 | $63,000 | +687.5% | 5,820 | +193.9% | 0.00% | – |
| Q2 2014 | $8,000 | – | 1,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |